In this double-blind , randomized sham-controlled trial , subjects received subcutaneous injections of granulocyte colony-stimulating factor ( 10 g/kg per day ) for 5 days , followed by leukapheresis , and intramuscular administration of 50-400 million sorted CD133 + cells delivered into both legs .